Dr Catherine Elliott: key facts
- Kind of voice
- Sector leader
- Role
- Cancer Research UK's director of research
- Quoted on
- Cancer
- Tracked press citations
- 2
- Most recently quoted
- 29 Sept 2026
“Enhertu is a targeted treatment that delivers chemotherapy directly to cancer cells. Clinical trial results show that, for people with HER2-low advanced breast cancer whose disease has progressed following treatment, it can help them live longer and delay their cancer from getting worse compared with standard chemotherapy.”
What Dr Catherine Elliott has said
“Preventing cancer cases saves lives, and finding new ways to do this is key to our efforts to beat cancer. There is increasing evidence that in certain groups of people, low-dose aspirin can offer protection from bowel cancer.”
Director of research at Cancer Research UK · Cancer · 27 Aug 2026 · Aspirin can have ‘huge effect’ in stopping colorectal cancer returning, study finds ↗
Where Dr Catherine Elliott has been quoted
- Women in England with incurable breast cancer to get life-extending drug on NHStheguardian.com · 29 Sept 2026
- Aspirin can have ‘huge effect’ in stopping colorectal cancer returning, study findstheguardian.com · 27 Aug 2026
Related media coverage
Recent UK press coverage of their topics — not necessarily citing them directly.
Chief executives, directors and spokespeople of trade bodies, representative associations and charities speaking for the sector. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 5 Oct 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.